50.75
+0.97%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Qingdao NovelBeam Technology Co
Its shares trade on Shanghai under the ticker 688677.SS. It has been listed since 26 February 2021. In the fiscal year to 31 December 2025, it reported revenue of CN¥602.6m and net income of CN¥171.6m. At that date it held total assets of CN¥1.63bn and shareholders' equity of CN¥1.35bn.
Qingdao NovelBeam Technology Co., Ltd. engages in the research and development of optics technology, the manufacture of optical instruments, and the provision of design solutions for medical, life science, laser, and micro-display projection applications. The company is headquartered in Qingdao, Shandong. The company went IPO on 2021-02-26. Its main products of medical endoscope equipment include fluorescent endoscopes, fluorescent camera adapters/adaptive lenses, fluorescent light source modules and white light source modules. Its medical endoscopic equipment products are mainly used in abdominal endoscopic surgery such as liver and gallbladder and gastrointestinal surgery. Its optical products mainly include medical optical products, industrial and laser optical products, and biometric products. Among them, the biometric products include fingerprint devices, palmprint devices and related accessories. In addition, the Company also provides technical services and house leasing services. The firm distributes its products both in the domestic market and to overseas markets.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 26 Feb 2021
- Employees
- 854
- Website
- novelbeam.com ↗
Leadership
Pay as last reported
- Mr. Anmin ZhengChairman of the Board, since 2010CN¥1.9m
- Mr. Fanghua WangChief Financial Officer, Deputy General Manager, Secretary of the BoardCN¥944,200
- Mr. Yao ZhengGeneral Manager, Director, since 2010CN¥1.5m
- Mr. Changming GuDeputy General Manager, Director, Chief R&D Center Officer, since 2016CN¥1.2m
- Ms. Xin LiuStaff Elected Director
- Mr. Liang ZhouDirector
- Mr. Yong LiIndependent Director
- Mr. Youqiang SongIndependent Director
- Mr. Ming WangIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Qingdao NovelBeam Technology employs 854 full-time employees in Health Care sector.
- Medical endoscope equipment includes fluorescent endoscopes and camera adapters.
- Biometric products feature fingerprint and palmprint devices for security applications.
Weaknesses
- The company's main products focus on medical endoscopic equipment and optical instruments.
- Qingdao NovelBeam Technology has no mention of international expansion plans.
- The company's technical services are limited to domestic and overseas markets.
Opportunities
- The Health Care sector offers growth in medical endoscopic surgery applications.
- Biometric products can expand into new security markets globally.
- Optical instruments for laser and micro-display projection have emerging demand.
Threats
- Competition in the Health Care sector may increase with new entrants.
- The medical endoscopic equipment market faces regulatory challenges.
- Biometric product demand could fluctuate with security technology trends.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.